Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Akantior in Acanthamoeba Keratitis
NCT03274895Phase 3Completed
- Sponsor
- SIFI SpA
- Start
- Aug 2017
- Primary completion
- Jun 2021
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of polihexanide in Acanthamoeba keratitis (AK), sponsored by SIFI SpA. Started Aug 2017; status: completed.
02
Drugs
polihexanide
03
Conditions
Acanthamoeba keratitis (AK)
Beyond the preview
Go deeper on NCT03274895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03274895.